1. Home
  2. MYFW vs CRVS Comparison

MYFW vs CRVS Comparison

Compare MYFW & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MYFW

First Western Financial Inc.

N/A

Current Price

$29.74

Market Cap

312.1M

Sector

Finance

ML Signal

N/A

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

N/A

Current Price

$10.93

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MYFW
CRVS
Founded
2002
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
312.1M
1.3B
IPO Year
2018
2016

Fundamental Metrics

Financial Performance
Metric
MYFW
CRVS
Price
$29.74
$10.93
Analyst Decision
Hold
Strong Buy
Analyst Count
3
8
Target Price
$33.00
★ $33.14
AVG Volume (30 Days)
35.4K
★ 897.5K
Earning Date
10-22-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 54.02
48.04
EPS
★ 1.20
N/A
Revenue
★ $96,914,000.00
N/A
Revenue This Year
$12.88
N/A
Revenue Next Year
$8.10
N/A
P/E Ratio
$25.23
★ N/A
Revenue Growth
★ 7.60
N/A
52 Week Low
$22.00
$6.39
52 Week High
$34.36
$26.95

Technical Indicators

Market Signals
Indicator
MYFW
CRVS
Relative Strength Index (RSI) 32.30 36.67
Support Level $27.71 $11.13
Resistance Level $30.00 $13.73
Average True Range (ATR) 0.59 0.69
MACD -0.09 -0.09
Stochastic Oscillator 0.00 19.00

Price Performance

Historical Comparison
MYFW
CRVS

About MYFW First Western Financial Inc.

First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: